ArticleActa crystallographica. Section D, Structural biology2026
Alphafuser: a parsimonious approach to predicting higher-order protein complexes.
Article in Acta crystallographica. Section D, Structural biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Many biological processes rely on the activity of multiple proteins acting in concert as part of higher-order oligomeric complexes. However, the majority of structural studies have routinely simplified these systems to examine only one or a few protein partners of a multi-component system. Artificial intelligence (AI) methods implemented in AlphaFold, RoseTTAFold, ESMFold and others have revolutionized our ability to not only predict the fold of individual proteins, but also to predict that of complex assemblies. A major bottleneck in exploiting AI-based protein fold prediction for multiprotein complexes, however, is identifying likely interacting partners from a given interactome. Here, we present a protein complex prediction pipeline based on AlphaFold, called Alphafuser, that combines experimental interaction data with systematic querying of possible combinations of protein partners in a computationally parsimonious manner. This versatile protein complex prediction pipeline creates a queue of all potential complexes, up to a user defined number of partners. Because a complete search of all permutations is not typically practical, we implemented a simple dead-end trimming algorithm from the dimer step onwards based on the interface probability template modeling (ipTM) score to remove low-probability subcomplexes from the queue of higher-order complexes. Experimentally structurally characterized multiprotein complexes in the Protein Data Bank, PP2A-B56γ1 holoenzyme-PME-1 complex, the human γ-secretase complex, the TFIIIC complex and the TRAPP I complex, were used to obtain a general ipTM cutoff parameter for the pipeline and to confirm that complexes without extensive direct contacts between all subunits could be identified. We applied Alphafuser to two test cases starting from yeast two-hybrid and co-immunoprecipitation/mass spectrometry (co-IP/MS) interaction data. These predictions were tested experimentally using pull-down assays, confirming direct interactions of the proteins identified computationally by the Alphafuser pipeline.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.